Guest guest Posted February 21, 2011 Report Share Posted February 21, 2011 February 21, 2011 HCV » February Newsletter » HCV Fact Sheets » Educational Materials » HCSP Streaming Videos Greetings: This was another incredible week with news about hepatitis C. The most important news item was the press release from Tibotec announcing the start of phase III studies of their once-a-day dose of TMC-435-an HCV protease inhibitor. Stay tuned for information about this drug - in addition to the once-a-day dosing the preliminary data from the phase II studies looks very promising. 2. In addition to the Tibotec news you might want to check out what others are reading about hepatitis B and hepatitis C. The Top Ten English and Spanish fact sheets include Acetaminophen and Your Liver, Short Term Disability, and more. On the HBV Advocate the Top Ten includes How to Interpret Hepatitis B Antibody and Viral Tests, Hepatitis B Antigen and Antibody Tests and many more. 3. Jacques Chambers monthly column is on "Taxation of Disability Benefits" - a must read if you are paying into disability and want to make sure you are reporting the income correctly. 4. Centerforce in cooperation with San Quentin and prison peer educators have produced three videos titled "Mythbusters, which you can find on our Patient Education page under streaming videos." Feel free to pass these around to other prisons that are educating peers about hepatitis C. 5. Our HCSP Training Calendar has been updated through April 2011. If you are interested in attending one of our trainings the flyers will soon be available for the confirmed dates and locations so that you can find out more information on how to register. 6. Lastly, the CDC in cooperation with AASLD is sponsoring a Hepatitis Single Topic Conference on June 4-5, 2011 in Atlanta, GA. The conference topic is "Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment." Don't forget to keep checking out our blog for more about the most recent news stories. Sincerely,Alan Join us on Twitter - . Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org Editor-in-Chief, HBV Advocate www.hbvadvocate.org . **Questions and Comments: Questions and/or comments can be directed to alanfranciscus@... **To receive the eblast in your email inbox simply send an e-mail to: listserv@... with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case. .. HBV » HBV Journal Review » HBV Factsheets » HBV & HCV Advocate Hepatitis Blog » Stay connected with all the late-breaking news on hepatitis B-Join us on Twitter Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.